5 registrations that name flaxseed as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 5 registrations
Status
All 5 registrations
RecruitingNCT05088863
Survey Assessing How Consumers Adapt Their Diet in Response to Health Claim Messaging
No phase
St. Boniface Hospital
About 384 people
Started Mar 3, 2022
In plain words A study of flaxseed in people 18 and older, run by St. Boniface Hospital. It plans to enroll about 384 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older; healthy volunteers accepted. Conditions: Health Claim Implementation.
Man or woman, age ≥18 years;
Willing to provide informed consent;
Willing/able to comply with the requirements of the study;
Have a mailing address in the Winnipeg census metropolitan area (City of Winnipeg and the municipalities of West St. Paul, East St. Paul, Headingley, Macdonald, Richot, Tache, Springfield, Rosser, St. Francois Xavier and St. Clements)4.
The exclusion criteria are on the listing.
What it tests, as registered
flaxseed
Registered summary
A survey designed to examine how consumers adapt their diet in response to health claim messaging.
Where, as registered
No US site; Canada (1).
RecruitingNCT04824053
Effects of UNICLA-A2 Dairy Products on Patients at High-risk of Colorectal Cancer Development
No phase
Instituto de Investigación Sanitaria Aragón
About 34 people
Started Feb 28, 2022
In plain words A study of flaxseed in people 18 to 80, run by Instituto de Investigación Sanitaria Aragón. It plans to enroll about 34 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 80. Conditions: Colorectal Polyp.
Participants diagnosed with high-risk polyps in the colorectal cancer screening programme or in the relative's colon cancer prevention program or patients who are in follow-up due to prior detection of polyps with any of the following…
At least 10 adenomas
At least 5 proximal serrated polyps (PSP)
At least 2 serrated polyps with diameters ≥10 mm
7 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Milk from genetically selected homozygous- β-casein-A2 cows fed with forages and a concentrate enriched on linseed and selenized yeast as sources of PUFAs and selenium; Conventional milk; Yogurt made from milk of genetically selected homozygous- β-casein-A2 cows fed with forages and a concentrate enriched on linseed and selenized yeast as sources of PUFAs and selenium; Conventional yogurt; Fresh cheese made from milk of genetically selected homozygous- β-casein-A2 cows fed with forages and a concentrate enriched on linseed and selenized yeast as sources of PUFAs and selenium; Conventional fresh cheese
Registered summary
Dietary intervention with UNICLA-A2 milk products containing beta casein A2 protein, and higher levels of omega-3 fatty acids and selenium may contribute to maintain the intestinal integrity, reduce inflammatory processes, normalize the immune system, protect against oxidative damage and equilibrate the gut microbiota in high-risk colorectal cancer patients who have undergone polypectomy
Where, as registered
No US site; Spain (1).
Not yet recruitingNCT06911060
Flaxseed Consumption on Biochemical and Quality of Life in Type 2 Diabetes
No phase
Ondokuz Mayıs University
About 46 people
Starts Sep 2025 (estimated)
In plain words A study of flaxseed in people 19 to 65, run by Ondokuz Mayıs University. It plans to enroll about 46 people and lists no sites yet.
Who it lists and where
Who the trial lists, as registered
Lists people 19 to 65. Conditions: Type 2 Diabetes Mellitus (T2DM).
Diagnosed with T2DM by a physician
Being between the ages of 19-65
Having a body mass index (BMI) between 20-35 kg/m2
Using oral anti-diabetics and not using insulin
The exclusion criteria are on the listing.
What it tests, as registered
Flaxseed; Diet
Registered summary
The main goal of this clinical trial is to determine the effect of flaxseed added to the diet on biochemical parameters and quality of life in patients with Type 2 diabetes mellitus (T2DM). The main questions it aims to answer are: * Does flaxseed supplementation given to T2DM patients for 12 weeks have an effect on biochemical parameters? * Does flaxseed supplementation given to T2DM patients for 12 weeks have an effect on quality of life? Researchers will compare patients with T2DM consume diet added flaxseed to a control group to see if flaxseed effect on biochemical parameters and quality… The full summary is on the listing.
Where, as registered
No sites listed yet.
Not yet recruitingNCT07530965
Omega-3-Fatty Acids in Children With Sickle Cell Disease
No phase
University of Alabama at Birmingham
About 20 people
Starts Dec 1, 2026 (estimated)
In plain words A study of flaxseed in people 5 to 18, run by University of Alabama at Birmingham. It plans to enroll about 20 people and lists no sites yet.
Who it lists and where
Who the trial lists, as registered
Lists people 5 to 18. Conditions: Sickle Cell Disease (SCD).
What it tests, as registered
Flaxseed
Registered summary
The purpose of this feasibility study is to investigate the role of a dietary supplement in modulating the gut microbiota and improving pain outcomes in children with sickle cell disease (SCD).
Where, as registered
No sites listed yet.
Not yet recruitingNCT06491095
Effect of Flax in Yogurt on Blood Cyanide Levels
No phase
St. Boniface Hospital
About 12 people
Starts Jan 16, 2025 (estimated)
In plain words A study of flaxseed in people 18 and older, run by St. Boniface Hospital. It plans to enroll about 12 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older; healthy volunteers accepted. Conditions: Healthy.
Generally healthy adult, 18 years or older;
Willing to provide informed consent;
Willing/able to comply with the requirements of the study.
The exclusion criteria are on the listing.
What it tests, as registered
0 g Flax; 40 g whole ground flaxseed; 40 g roasted then ground whole flaxseed; 40 g of whole intact flaxseeds; 28 g flax hulls
Registered summary
A randomized, controlled, cross-over post-prandial trial in healthy human volunteers will be conducted at the IH Asper Institute to determine the effect whole ground flaxseed, roasted then ground whole flaxseed, whole intact flaxseed and flaxseed hulls mixed into yogurt on blood cyanide levels.